A long-running confirmatory trial of two of Sarepta Therapeutics’ Duchenne muscular dystrophy drugs has missed its main goal.
Dear Savvy Senior, With a longtime vaccine critic leading the nation’s health departments, can you give me updated ...
NanoViricides, Inc. (NYSE American: NNVC ) (the "Company"), a clinical stage leader developing revolutionary broad-spectrum antiviral drugs that the virus cannot escape, announced that it will be ...
5hon MSN
What's the Deal With COVID Testing Now? Doctors Explain When to Test, How to Get Them and More
A PCR test detects the actual genetic material of the virus and involves a step that amplifies the presence of any material ...
New diagnostic kits aim to revolutionize early screening of the disease, potentially allowing patients to receive treatments—such as monoclonal antibodies—sooner.
The INSTI® HIV Self Test delivers highly accurate results in 60 seconds or less, the fastest home-use HIV rapid test available. FDA-approved and ready for U.S. consumers, providing a private and ...
The test detects higher levels of a protein known to be associated with the disease. Secret Service finds 17 'skimming' devices in tour of San Antonio businesses Bombshell report shows foreign ...
Augurex’s Spinestat diagnostic test earned the FDA’s breakthrough device designation. Spinestate is a 14-3-3eta autoantibody multiplex immunoassay test for diagnosing axial spondyloarthritis, ...
Libtayo is approved for adjuvant treatment in high-risk CSCC patients post-surgery and radiation, showing significant disease-free survival benefits in the C-POST trial. The C-POST trial excluded ...
Hosted on MSN
FDA vaccine official restricted COVID vaccine approvals against the advice of agency staff
The government’s top vaccine official working under Health Secretary Robert F. Kennedy Jr. recently restricted the approval of two COVID-19 vaccines, disregarding recommendations from government ...
Nearly every Republican senator signed a letter Thursday urging the Food and Drug Administration (FDA) to reverse its decision to approve a “generic” version of the abortion pill mifepristone, which ...
The U.S. Food and Drug Administration has given clearance to another blood test to help assess Alzheimer’s disease and other causes of cognitive decline, providing a broader understanding of when the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results